1. AB0419 Aurion Study: Preliminary Results of Voclosporin in Lupus Nephritis. (15th July 2016) Authors: Yahya, R.; Gafor, A.H.B.A.; Huizinga, R.; Chan, T.M.; Solomons, N. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 1049 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. OP0277 AURORA PHASE 3 STUDY DEMONSTRATES VOCLOSPORIN STATISTICAL SUPERIORITY OVER STANDARD OF CARE IN LUPUS NEPHRITIS (LN). (2nd June 2020) Authors: Arriens, C.; Polyakova, S.; Adzerikho, I.; Randhawa, S.; Solomons, N. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 172 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. SAT0186 DEVELOPING PREDICTORS OF GLOBAL BILAG TREATMENT RESPONSE IN PATIENTS WITH LUPUS NEPHRITIS: MORE LESSONS FROM THE ASPREVA LUPUS MANAGEMENT STUDY GROUP (ALMS) DATA. (2nd June 2020) Authors: Mcdonald, S.; Yiu, S.; Su, L.; Gordon, C.; Solomons, N.; Bruce, I. N. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 1034 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗